Research progress of exogenous pulmonary surfactant in the treatment of neonatal respiratory distress syndrome
10.3969/j.issn.1000-3606.2018.06.017
- VernacularTitle:外源性肺表面活性物质治疗新生儿呼吸窘迫综合征研究进展
- Author:
Wenya QIAN
1
Author Information
1. 上海同济大学附属同济医院 儿科 上海 200065
- Keywords:
exogenous pulmonary surfactant;
neonatal respiratory distress syndrome;
replacement therapy
- From:
Journal of Clinical Pediatrics
2018;36(6):476-479
- CountryChina
- Language:Chinese
-
Abstract:
Exogenous pulmonary surfactant (PS) has been widely applied in the treatment of neonatal respiratory distress syndrome (NRDS), and its curative effect was confirmed. However, there is still controversy about the dosage, timing of administration and the routes of administration. This article reviews the progress of the application of PS in NRDS in recent 3 years, and provides a basis for strategies of clinical diagnosis and treatment.
